INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 21S · 3 late76 trades$25.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

18,937 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$101K
1,212 sh
Jan 5, 2026Jan 7, 2026
Page 385 of 474
← PrevNext →
traded Jan 5, 2026
+2d
SEC Form 4

Evidence

21
GM
Gallagher Daniel Martin JrChief Legal Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$96K
800 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

21
GM
Gallagher Daniel Martin JrChief Legal Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$85K
716 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

21
GM
Gallagher Daniel Martin JrChief Legal Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$167K
1,400 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

21
DM
Dippold MichaelEVP and CFO
DRSLeonardo DRS, Inc.
Open-market sale · 10b5-1 plan
SELL$392K
10.6K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

21
PT
Pinner Jeffrey TsviChief Technology Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$48K
400 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

19
Armstrong BrianDirector, Chairman and CEO, 10% Owner
COINCoinbase Global, Inc.
Open-market sale · 10b5-1 plan
SELL$5.17M
20.8K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

19
IJ
Inrig JulaCHIEF MEDICAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$82K
2,031 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

19
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Open-market sale · 10b5-1 plan
SELL$1.88M
166.4K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

19
Armstrong BrianDirector, Chairman and CEO, 10% Owner
COINCoinbase Global, Inc.
Open-market sale · 10b5-1 plan
SELL$4.72M
18.9K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

19
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Open-market sale · 10b5-1 plan
SELL$727K
42.5K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

18
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$38K
448 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

18
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1,491
18 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

18
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$5,017
63 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

18
SH
Sauer Richard HarryChief Legal Officer & Secty
WDAYWorkday, Inc.
Open-market sale · 10b5-1 plan
SELL$237K
1,130 sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

18
ER
Enslin RobertPresident, CCO
WDAYWorkday, Inc.
Open-market sale · 10b5-1 plan
SELL$245K
1,155 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

18
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$11K
137 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

18
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2,937
36 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

18
AL
Alpern Paul LVP and General Counsel
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$73K
4,318 sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

18
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$9,846
127 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

18
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$9,309
119 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

17
KS
Kazmaier Gerrit SPresident, Prod. and Tech.
WDAYWorkday, Inc.
Open-market sale · 10b5-1 plan
SELL$301K
1,437 sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

16
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$96K
8,000 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

16
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$95K
8,000 sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

16
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$78K
6,700 sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

16
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$63K
5,400 sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

16
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$64K
5,400 sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

16
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$80K
6,700 sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

16
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$2.82M
632.9K sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

16
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$93K
8,000 sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

16
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$65K
5,400 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

16
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$2.80M
632.9K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

16
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$2.97M
632.9K sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

16
IJ
Inrig JulaCHIEF MEDICAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$17K
445 sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

16
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$80K
6,700 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

15
OO
Okupe OluyemiChief Financial Officer
HIMSHims & Hers Health, Inc.
Open-market sale · 10b5-1 plan
SELL$306K
9,070 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

15
WS
Wallace SallyEVP, Chief Operating Officer
DRSLeonardo DRS, Inc.
Open-market sale · 10b5-1 plan
SELL$46K
1,300 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

14
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$25K
3,938 sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

14
GC
Gibson ChristopherDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$170K
40.0K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

14
KS
Kazmaier Gerrit SPresident, Prod. and Tech.
WDAYWorkday, Inc.
Open-market sale · 10b5-1 plan
SELL$173K
822 sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence